Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for NTRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 143.07M
March 31, 2026 144.95M
December 31, 2025 118.47M
September 30, 2025 104.38M
June 30, 2025 102.74M
March 31, 2025 103.06M
December 31, 2024 96.59M
September 30, 2024 385.50M
June 30, 2024 344.83M
March 31, 2024 347.43M
December 31, 2023 349.97M
September 30, 2023 350.91M
June 30, 2023 353.39M
March 31, 2023 355.83M
December 31, 2022 358.23M
September 30, 2022 359.80M
June 30, 2022 346.44M
March 31, 2022 348.18M
December 31, 2021 341.43M
September 30, 2021 328.47M
June 30, 2021 329.30M
March 31, 2021 330.28M
December 31, 2020 223.74M
September 30, 2020 221.40M
June 30, 2020 220.59M
Date Value
March 31, 2020 97.61M
December 31, 2019 99.95M
September 30, 2019 101.41M
June 30, 2019 102.79M
March 31, 2019 104.10M
December 31, 2018 73.36M
September 30, 2018 73.28M
June 30, 2018 73.21M
March 31, 2018 73.14M
December 31, 2017 73.06M
September 30, 2017 73.20M
June 30, 2017 0.00
March 31, 2017 0.00
December 31, 2016 0.00
September 30, 2016 0.00
June 30, 2016 0.00
March 31, 2016 0.00
December 31, 2015 0.00
September 30, 2015 21.28M
June 30, 2015 27.77M
March 31, 2015 28.03M
September 30, 2014 0.00
June 30, 2014 0.00
March 31, 2014 0.00

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Guardant Health, Inc. 1.669B
CareDx, Inc. 13.20M
Myriad Genetics, Inc. 203.20M
BioRestorative Therapies, Inc. 0.00
Exagen, Inc. 26.68M